Pay in 4 interest-free payments of $6.95 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
FIDAS-5, an orally active methionine adenosyltransferase 2A (MAT2A) inhibitor that blocks SAM production, successfully impaired leukemia progression in patient-derived xenograft models, and a drug screen revealed strong synergy between MAT2A inhibition and histone deacetylase inhibitors
Similar content being viewed by others Subjects Introduction The discovery of insulin in 1921 was a milestone event 1 that introduced the possibility of systematic research of insulin action (Fig
Structurally, it represents the first 29 amino acids of endogenous GHRH, a sequence theorized to retain much of the biological signaling activity associated with the naturally occurring peptide
Cell Changes : Significantly increased number of mononuclear cells infiltrating the dermis
US$ 24.17
US$ 25.79
US$ 25.90
US$ 25.62
US$ 21.73
US$ 23.31
US$ 20.75
US$ 21.17
US$ 21.50
US$ 22.06
US$ 23.63
